Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo …
TP Lodise Jr, B Lomaestro, KA Rodvold… - Antimicrobial agents …, 2004 - Am Soc Microbiol
The primary objectives of this analysis were to determine which pharmacokinetic model
most accurately describes the elimination pathways for piperacillin in the presence of …
most accurately describes the elimination pathways for piperacillin in the presence of …
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo …
TP Lodise Jr, B Lomaestro… - Antimicrobial …, 2004 - pubmed.ncbi.nlm.nih.gov
The primary objectives of this analysis were to determine which pharmacokinetic model
most accurately describes the elimination pathways for piperacillin in the presence of …
most accurately describes the elimination pathways for piperacillin in the presence of …
[PDF][PDF] Pharmacodynamic Profiling of Piperacillin
M Carlo - Citeseer
MATERIALS AND METHODS Population of hospitalized patients. The plasma concentration-
time data for piperacillin-tazobactam in hospitalized patients were provided by Wyeth-Ayerst …
time data for piperacillin-tazobactam in hospitalized patients were provided by Wyeth-Ayerst …
[引用][C] Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo …
TP LODISE, B LOMAESTRO… - Antimicrobial …, 2004 - pascal-francis.inist.fr
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the
use of population pharmacokinetic models and Monte Carlo simulation CNRS Inist …
use of population pharmacokinetic models and Monte Carlo simulation CNRS Inist …
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo …
TP Lodise Jr, B Lomaestro, KA Rodvold… - Antimicrobial Agents …, 2004 - europepmc.org
The primary objectives of this analysis were to determine which pharmacokinetic model
most accurately describes the elimination pathways for piperacillin in the presence of …
most accurately describes the elimination pathways for piperacillin in the presence of …
[引用][C] Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo …
TP LODISE Jr - Antimicrob Agents Chemother, 2004 - cir.nii.ac.jp
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through
the use of population pharmacokinetic models and Monte Carlo simulation | CiNii Research …
the use of population pharmacokinetic models and Monte Carlo simulation | CiNii Research …
[PDF][PDF] Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo …
TP Lodise Jr, B Lomaestro, KA Rodvold… - ANTIMICROBIAL …, 2004 - researchgate.net
MATERIALS AND METHODS Population of hospitalized patients. The plasma concentration-
time data for piperacillin-tazobactam in hospitalized patients were provided by Wyeth-Ayerst …
time data for piperacillin-tazobactam in hospitalized patients were provided by Wyeth-Ayerst …
[PDF][PDF] Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo …
TP Lodise Jr, B Lomaestro, KA Rodvold… - ANTIMICROBIAL …, 2004 - academia.edu
MATERIALS AND METHODS Population of hospitalized patients. The plasma concentration-
time data for piperacillin-tazobactam in hospitalized patients were provided by Wyeth-Ayerst …
time data for piperacillin-tazobactam in hospitalized patients were provided by Wyeth-Ayerst …
[HTML][HTML] Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo …
TP Lodise Jr, B Lomaestro, KA Rodvold… - Antimicrobial Agents …, 2004 - ncbi.nlm.nih.gov
The primary objectives of this analysis were to determine which pharmacokinetic model
most accurately describes the elimination pathways for piperacillin in the presence of …
most accurately describes the elimination pathways for piperacillin in the presence of …